St. Jude Medical Announces CE Mark Approval Of EnligHTN Renal Denervation System

(RTTNews) - St. Jude Medical Inc. (STJ), a global medical device company, announced the CE Mark approval of its next-generation EnligHTN Renal Denervation System for treating patients with drug-resistant, uncontrolled hypertension.

The system features an advanced generator that delivers simultaneous ablations via a multi-electrode catheter, reducing total ablation time with the new EnligHTN system by more than 80 percent in comparison to the first generation system, from approximately 24 minutes to four minutes.

Renal denervation is a catheter-based ablation procedure used to treat patients with drug-resistant hypertension.